Open AccessRole of resveratrol and chrysin on inflammation and liver function in obese mice
Author(s) -
Pipit Pitriani,
AUTHOR_ID,
Lee Wanglok,
Hee-Geun Park,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2021
Publication title -
maǧallaẗ al-abḥāṯ al-handasiyyaẗ
Language(s) - English
Resource type - Journals
eISSN - 2307-1885
pISSN - 2307-1877
DOI - 10.36909/jer.asseee.16071
Subject(s) - resveratrol , chrysin , endocrinology , medicine , inflammation , chemistry , liver function , pharmacology , biochemistry , antioxidant , flavonoid
The incidence of obesity has been spreading throughout the world. Many of the complications caused by obesity, such as inflammation and impaired liver function. This study aimed to determine the effect of supplementation resveratrol and chrysin on inflammation and liver function of obese mice fed a high-fat diet. 40 mice (C57BL/6) were randomly divided into four groups: 10 in the normal diet (NC), 10 control group on a high-fat diet (HC), 10 in the high-fat diet with resveratrol (HRE), and 10 in the high-fat diet group with chrysin (HCH). Resveratrol 25 mg and 50mg of chrysin supplement per kg body weight were orally given with 0.1ml solution of Dimethyl Sulfoxide (DMSO) dissolved in for 15 weeks (4 times/week). The calorie intake of the group supplemented by resveratrol and chrysin significantly decreased. Group with high-fat diet, resveratrol, and chrysin increased body weight significantly compared to the normal diet group. The liver weight decreased in the resveratrol but not in the chrysin group. TNFα did not decrease in the resveratrol and chrysin group while IL1β significantly decreased. TLR 4 significantly decreased only in the chrysin group, while IL10 only increased in the resveratrol group. The collagen was decreased by resveratrol and chrysin supplementation while fibronectin was not affected by resveratrol or chrysin. The inflammatory process in the liver of obese mice fed a high-fat diet can be reduced by supplementing resveratrol and chrysin.